Home
>
National Drug Code (NDC)
>
NAROPIN
NAROPIN - 63323-286-37 - (ROPIVACAINE HYDROCHLORIDE MONOHYDRATE)
Drug Information of NAROPIN
| Product NDC: | 63323-286 |
| Proprietary Name: | NAROPIN |
| Non Proprietary Name: | ROPIVACAINE HYDROCHLORIDE MONOHYDRATE |
| Active Ingredient(s): | 5 mg/mL & nbsp; ROPIVACAINE HYDROCHLORIDE MONOHYDRATE |
| Administration Route(s): | EPIDURAL; INFILTRATION; PERINEURAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NAROPIN
| Product NDC: | 63323-286 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020533 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090804 |
Package Information of NAROPIN
| Package NDC: | 63323-286-37 |
| Package Description: | 1 VIAL in 1 BOX (63323-286-37) > 30 mL in 1 VIAL |
NDC Information of NAROPIN
| NDC Code | 63323-286-37 |
| Proprietary Name | NAROPIN |
| Package Description | 1 VIAL in 1 BOX (63323-286-37) > 30 mL in 1 VIAL |
| Product NDC | 63323-286 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ROPIVACAINE HYDROCHLORIDE MONOHYDRATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | EPIDURAL; INFILTRATION; PERINEURAL |
| Start Marketing Date | 20090804 |
| Marketing Category Name | NDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | ROPIVACAINE HYDROCHLORIDE MONOHYDRATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |
